BPC-157 and TB-500 Stack: Prescription Options and Monthly Cost
Compounded BPC-157 and TB-500 are sterile injectable peptides that some U.S. providers prescribe together to support soft-tissue repair. Because neither drug is FDA-approved, the entire cost is cash-pay and can vary widely depending on dose, pharmacy, and consultation fees.
A legal prescription for a BPC-157 + TB-500 stack requires a licensed U.S. prescriber, a 503A or 503B compounding pharmacy, and patient-specific dosing that justifies why each peptide is needed. Your monthly cost is the sum of (1) the consultation or membership fee, (2) the pharmacy’s price per milligram of each peptide, and (3) shipping and supplies. Insurance rarely covers compounded peptides, so most patients pay the entire amount out of pocket.
- The FDA’s July 23-24, 2026 PCAC meeting reviewed both peptides for possible inclusion on the 503A Bulks List but has not yet issued a final decision.(fda.gov)
- 61 % of compounding pharmacies do not accept insurance for any compounded preparation, according to the Alliance for Pharmacy Compounding 2025-2026 Snapshot.(a4pc.org)
What BPC-157 and TB-500 Are
BPC-157 is a synthetic version of a fragment of body protection compound (BPC) found in human gastric juice, while TB-500 is the active region of thymosin β4, a naturally occurring 43-amino-acid protein. Neither peptide has FDA approval for any indication, but both are compounded under section 503A for patient-specific prescriptions when a prescriber documents a clinical need. The July 2026 FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed both substances for safety, effectiveness evidence, and historical use.(fda.gov)
Regulatory status: Because the FDA has not approved either peptide, pharmacies must prepare them only after receiving a valid prescription and must follow USP <797> sterile compounding standards. Marketing claims cannot state clinical efficacy.
How the Stack May Work Synergistically
The rationale for stacking is that BPC-157 appears to accelerate fibroblast migration and collagen deposition, while TB-500 promotes angiogenesis and modulates inflammatory cytokines. Animal studies show faster tendon-to-bone healing with BPC-157,(pubmed.ncbi.nlm.nih.gov) and more rapid capillary formation and wound closure with thymosin β4 derivatives.(pubmed.ncbi.nlm.nih.gov)
Potential complementary effects:
- Angiogenesis vs. collagen remodeling: TB-500 increases vascular endothelial growth factor (VEGF) expression, whereas BPC-157 up-regulates type-I collagen mRNA.
- Inflammation control: TB-500 down-regulates NF-κB pathway mediators, while BPC-157 has been shown to reduce TNF-α in rodent gut-injury models.
- Cell migration: Both peptides stimulate keratinocyte and fibroblast migration, potentially shortening the proliferation phase of healing.
Legal Prescription Pathways in the U.S.
U.S. law allows compounded peptides only when a licensed prescriber writes a patient-specific prescription and a state-licensed 503A (or FDA-registered 503B) pharmacy compounds the product. The FDA cautions that compounded drugs are not FDA-approved and do not undergo pre-market review.(fda.gov)
💡 Provider checklist
Before writing a peptide prescription, clinicians should document (1) why no FDA-approved drug meets the patient’s need, (2) why both peptides are required, and (3) the intended duration and follow-up plan. This documentation protects the prescriber under 503A.
Typical Dosing Schedules
Most prescribers start with a 4- to 6-week loading phase followed by a maintenance phase. Below is a summary of common protocols reported in clinical practice and in pre-clinical literature.
| Phase | BPC-157 Dose | TB-500 Dose | Frequency |
|---|---|---|---|
| Loading (Weeks 1-4) | 250-500 µg | 2-5 mg | BPC daily, TB-500 twice weekly |
| Maintenance (Weeks 5-12) | 250 µg | 2 mg | BPC every other day, TB-500 weekly |
| Discontinuation | Taper both peptides over 2 weeks to monitor rebound inflammation | ||
Patients with systemic conditions such as autoimmune arthritis may stay on a low maintenance dose past 12 weeks, but long-term safety data in humans are lacking.
Is a BPC-157 + TB-500 stack appropriate for you?
Check the column that fits your situation:
✅ Likely Appropriate
- Confirmed soft-tissue injury not responding to standard care
- No active malignancy or proliferative eye disease
- Able to self-inject or has caregiver support
- Understands treatment is off-label and experimental
🏥 See a Doctor First
- Pregnant or breastfeeding
- History of cancer within the last 5 years
- Poorly controlled diabetes or active infection
- On anticoagulants such as rivaroxaban or apixaban
Cost Breakdown: Every Line Item
Because compounded peptides are cash-pay, your monthly expense is the sum of several predictable charges. The table below lists each component so you can request an itemized quote.
| Cost Component | Typical Range | Evidence / Source |
|---|---|---|
| Initial telehealth or in-person visit | $50-$200 one-time | National telehealth fee surveys summarized by Alliance for Pharmacy Compounding, 2025 Snapshot (patients pay cash when insurance denies compounded meds).(a4pc.org) |
| BPC-157 peptide (per mg) | Priced by pharmacy; request per-mg quote | International Journal of Pharmaceutical Compounding stresses mg-based pricing for peptides (Jul/Aug 2026, vol 30 no 4).(ijpc.com) |
| TB-500 peptide (per mg) | Priced by pharmacy; request per-mg quote | Same IJPC report.(ijpc.com) |
| Sterile supplies (bacteriostatic water, syringes) | $15-$40 per month | See our guide on bacteriostatic water uses. |
| Cold-chain shipping | $20-$35 | USP <797> compliance requires overnight insulated packaging; cost estimates from USP supply-chain interview.(pharmacytimes.com) |
| Follow-up consults or membership | $0-$100 monthly | APC Snapshot: 20 % of pharmacies contract with telehealth companies that charge ongoing memberships.(a4pc.org) |
How to estimate your own monthly cost:
- Ask the pharmacy for its price per mg of each peptide.
- Multiply by your prescribed monthly milligrams (see dosing table above).
- Add the one-time or monthly provider fee, shipping, and supplies.
- Divide any one-time fees (e.g., consultation) by the number of months you plan to stay on therapy for a true month-over-month figure.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Sudden swelling or redness at the injection site - may indicate infection requiring antibiotics.
- Unexplained bruising or bleeding - peptides can affect platelet aggregation in some animal studies.
- Severe headache or vision changes - could signal increased intracranial pressure.
- Shortness of breath - report immediately to rule out allergic reaction.
- Rapid weight gain or edema - monitor for fluid retention.
- New or enlarging lumps - discontinue and evaluate for abnormal tissue growth.
- Signs of infection (fever > 100.4 °F) - sterile technique breach must be addressed.
- Mood changes or depression - though rare, neuropeptides can influence central pathways; call or text 988 if you have thoughts of self-harm.
Scientific References
- Pevec D et al. Gastric pentadecapeptide BPC-157 accelerates healing of transected rat Achilles tendon and stimulates tenocyte growth. J Orthop Res. 2003.
- Mann DL et al. Thymosin β4 accelerates wound healing. Ann N Y Acad Sci. 1999.
- Philp D et al. The regenerative peptide thymosin β4 accelerates dermal healing. J Invest Dermatol. 2012.
- U.S. Food & Drug Administration. Pharmacy Compounding Advisory Committee Briefing Document: BPC-157 and TB-500. July 23-24, 2026.
- Alliance for Pharmacy Compounding. Snapshot of Pharmacy Compounding in America 2025-2026. 2026.
- Jordan W, Vu N. Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards. Int J Pharm Compd. 2026.
Frequently Asked Questions
Is it legal to buy BPC-157 and TB-500 without a prescription?
No. U.S. federal law requires a valid prescription for patient-specific compounding. “Research-only” websites exist but sell unregulated products that may violate FDA rules and pose safety risks.
Do insurance plans ever reimburse compounded peptides?
Rarely. The Alliance for Pharmacy Compounding reports that only 25 % of pharmacies can bill some insurers for compounded medications, and even then approvals are case-by-case. Expect to self-pay.
How should I store reconstituted peptide vials?
Keep vials refrigerated at 36–46 °F (2–8 °C) and protect them from light. Discard 28 days after the first puncture unless the pharmacy’s stability data indicate a longer in-use period.
Can I draw both peptides into the same syringe?
Most pharmacies advise against mixing because stability and compatibility data are limited. Inject them separately unless your provider explicitly confirms a validated co-formulation.
What needles do I need?
A common setup is a 30-gauge, ½-inch insulin syringe for subcutaneous injections. See our guide to needle sizes for details.
How long until I feel improvement?
Animal data suggest histological improvements within 14 days, but patient-reported pain relief often takes 3–4 weeks. Always continue standard physical therapy.
Are there known drug interactions?
No formal interaction studies exist. However, both peptides may influence platelet activity, so discuss use if you take anticoagulants like rivaroxaban or apixaban.
Can I travel with peptide vials?
Yes, but carry them in a TSA-compliant cooler with ice packs and your prescription label. TSA allows injectable medications in reasonable quantities.
